XOMA to buy Kinnate; A pain biotech’s small IPO
Plus, news about Blueprint Medicines, Sosei Group and Poxel:
XOMA to buy Kinnate Biopharma: The biotech royalty aggregator said it would …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
